Eleven Biotherapeutics, a biopharmaceutical company designing and developing novel and differentiated protein-based biotherapeutics for ocular diseases, announced today that Abbie Celniker, PhD, Chief Executive Officer of Eleven Biotherapeutics is scheduled to provide a corporate update at the Stifel Nicolaus 2013 Healthcare Conference in Boston on Thursday, September 12, 2013 at 2:05 p.m. Eastern Time.
Help employers find you! Check out all the jobs and post your resume.
